{
  "data_version": "seed-0.6 · 2026-08-29",
  "source": "https://finance.foundation",
  "license": "CC BY 4.0",
  "entity": "company",
  "data": {
    "id": "eli-lilly",
    "name": "Eli Lilly",
    "legal_name": "Eli Lilly and Company",
    "ticker": "LLY",
    "exchange": "nyse",
    "country": "united-states",
    "sector": "Healthcare",
    "industry": "Pharmaceuticals",
    "market_cap_usd_bn": 750,
    "currency": "USD",
    "website": "https://www.lilly.com",
    "founded": 1876,
    "description": "Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.",
    "identifiers": {
      "lei": "FRDRIPF3EKNDJ2CQJL29",
      "isin": "US5324571083",
      "figi": "BBG001S5STL8"
    }
  },
  "links": {
    "html": "https://finance.foundation/companies/eli-lilly",
    "graph": "https://finance.foundation/api/v1/graph/companies/eli-lilly"
  }
}